There are 2789 resources available
153P - Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: Disease characteristics and endocrine therapy choice by menopausal status
Presenter: Shani Paluch-Shimon
Session: ePoster Display
154P - Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer
Presenter: Xavier Pivot
Session: ePoster Display
155P - The addition of pyrotinib in early or locally advanced HER2-positive breast cancer patients with no response to two cycles of neoadjuvant therapy: A prospective, multicenter study
Presenter: zhi gang YU
Session: ePoster Display
108P - A comprehensive pan-cancer study of fusions in Chinese cancer patients
Presenter: Mingwei Li
Session: ePoster Display
109P - A novel, comprehensive glimpse at NY-ESO-1 expression, mRNA to protein translation, & potential impact on clinical studies
Presenter: Kristin Blouch
Session: ePoster Display
110P - Novel genetic variants of CBS and COMT in the transsulfuration pathway genes are associated with survival of non-small cell lung cancer patients
Presenter: Yufeng Wu
Session: ePoster Display
111P - A study on the relationship between tumor fusion burden (TFB) and tumor immune microenvironment
Presenter: xiaoyu Liu
Session: ePoster Display
112P - Prognostic impact of five serum biomarkers in patients with advanced non-small cell lung cancer (NSCLC): An exploratory analysis
Presenter: Yomna Nassar
Session: ePoster Display
113P - The analysis of EGFR fusions characteristics in Chinese solid tumor patients
Presenter: Guibing Mao
Session: ePoster Display
114P - Changes in serum choline (Ch) levels to predict treatment outcomes in advanced cancer patients (pts) treated with immunotherapy (IO)
Presenter: Enrique Sanz Garcia
Session: ePoster Display